Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Industry News

New RE-VERSE AD™ Analyses Provide Additional Insights on Impact of Idarucizumab (Praxbind®) in Pradaxa® Patients with Gastrointestinal Bleeding or Needing Emergency Surgery

November 14, 2017

News Industry News

RE-DUAL PCI™ Results Offer Favorable New Safety Data on Pradaxa®

August 28, 2017

News Industry News

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

August 01, 2017

News Industry News

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

July 20, 2017

News Industry News

4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec

July 20, 2017

News Industry News

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

June 16, 2017

News Industry News

4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum

June 08, 2017

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

May 11, 2017

News Industry News

Abbott Announces CE Mark For Tacticath Contact Force Ablation Catheter, Sensor Enabled

May 09, 2017

News Industry News

Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor

May 08, 2017

News Industry News

Medtronic Receives CE Mark for Its Next Generation Cardiac Resynchronization Therapy-Pacemakers

February 28, 2017

Advertisement

New RE-VERSE AD™ Analyses Provide Additional Insights on Impact of Idarucizumab (Praxbind®) in Pradaxa® Patients with Gastrointestinal Bleeding or Needing Emergency Surgery

RE-DUAL PCI™ Results Offer Favorable New Safety Data on Pradaxa®

Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures

Fewer Leads, Fewer Complications: BIOTRONIK US Launches Proven DX Technology for Heart Failure Patients

4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

Abbott Announces CE Mark For Tacticath Contact Force Ablation Catheter, Sensor Enabled

Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor

Medtronic Receives CE Mark for Its Next Generation Cardiac Resynchronization Therapy-Pacemakers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content